Colitis ulcerative
Not recruitingStudy on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis
- Disease:Colitis ulcerative
- Substances:Mirikizumab
France- Participants:0–17 years
- Substances:Mirikizumab
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to France472 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.